Kliniska studier för Gliom i Tennessee
8 studier för Gliom söker deltagare vid platser i Tennessee.
Städer i Tennessee
Officiell studietext (engelska)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 1 okt. 2026 · NCT05099003A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- St. Jude Children's Research Hospital, Memphis
RekryterarFas 1/2
Upp till ålder 25 · Alla kön · Uppdaterad 25 sep. 2026 · NCT04094610SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Vanderbilt-Ingram Cancer Center, Nashville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- SCRI Oncology Partners, Nashville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT05916313A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
RekryterarFas 2
Ålder 8 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05503797Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
- Vanderbilt University Medical Center, Nashville
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juli 2026 · NCT07210632Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- St. Jude Children's Research Hospital, Memphis
RekryterarFas 2
Upp till ålder 3 · Alla kön · Uppdaterad 13 maj 2026 · NCT06528691A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT06326411Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.